Patent details

EP3549585 Title: ORALLY DISINTEGRATING TABLET OF EDOXABAN TOSYLATE HYDRATE

Basic Information

Publication number:
EP3549585
PCT Application Number:
JP2017042930
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178758306
PCT Publication Number:
WO2018101373
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORALLY DISINTEGRATING TABLET OF EDOXABAN TOSYLATE HYDRATE
French Title of Invention:
COMPRIMÉ ORODISPERSIBLE D'HYDRATE DE TOSYLATE D'EDOXABAN
German Title of Invention:
ORAL ZERFALLENDE EDOXABANTOSYLAT-HYDRAT TABLETTE
SPC Number:

Dates

Filing date:
30/11/2017
Grant date:
12/06/2024
EP Publication Date:
09/10/2019
PCT Publication Date:
07/06/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/06/2024
EP B1 Publication Date:
12/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/11/2024
Expiration date:
30/11/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2024
 
 

Name:
Daiichi Sankyo Company, Limited
Address:
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426, Japan (JP)

Inventor

1

Name:
KATO, Takafumi
Address:
Japan (JP)

2

Name:
KIKKAWA, Yoshito
Address:
Japan (JP)

Priority

Priority Number:
2016234259
Priority Date:
01/12/2016
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/444; A61P 7/02; A61K 47/38; A61K 47/36; A61K 47/32; A61K 47/26; A61K 47/18; A61K 47/12; A61K 9/20; A61K 9/00;

Publication

European Patent Bulletin

Issue number:
202424
Publication date:
12/06/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages